Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.
about
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesConcordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targetsComplement dependent cytotoxicity in chronic lymphocytic leukemia: ofatumumab enhances alemtuzumab complement dependent cytotoxicity and reveals cells resistant to activated complement.Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.Circulating Cytokines and Nitric Oxide are Involved in the Inhibition of Neutrophil Migration in Patients with Uterine Cervical NeoplasiaSkin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine stormNeuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.NK cell-based autologous immune enhancement therapy (AIET) for cancer.Neutrophils: important contributors to tumor progression and metastasis.Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity.The immunological function of CD52 and its targeting in organ transplantation.The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.Alemtuzumab induction of intracellular signaling and apoptosis in malignant B lymphocytes.Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists.Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study.A potent human neutralizing antibody Fc-dependently reduces established HBV infectionsRoles for Innate Immunity in Combination Immunotherapies.
P2860
Q21131216-29BE7403-3936-43F2-8355-CCE9AB931DD2Q26830569-134848B3-DCB5-434C-BEDB-0FA2F7DDEC68Q30356145-A053EE8A-F9F9-4B2D-8CBC-14B8D12CBEA5Q34413695-7FD2AA63-C531-44D9-9061-685C08E564A1Q35437978-593E9C43-C156-48D4-BAC4-B210BDFC18FFQ35569491-5239F4CD-327A-46F3-B0C0-54190A0F0751Q35586076-1490C00A-781A-47CD-9517-231F217D83BCQ36019028-DDF91FAE-20AB-4CB9-8F8C-BD984C097F39Q36026719-F46B4082-EC49-41F2-B0E3-0230B9968B1AQ36621100-BAFD0A22-3E08-4819-A733-9609E731114CQ36635664-A791E7C3-0573-46E6-A32A-A59642E44CA3Q37536206-56CB2E77-FF15-469C-8FC6-CFB1594E8147Q38585102-79F53EA2-5A00-40DC-A814-6AE27C685559Q38718037-13FFBE16-521E-434E-8182-933B694E3EBDQ38747419-7E01DC45-5C2C-441B-B37D-2CAC18E99E16Q38930113-1BB2D54B-B6B4-48C6-945F-4D8BF86B2D3DQ39474069-D626465C-E472-4560-8293-8D570858BC60Q39510365-C65A32A3-0C71-43A5-ADBA-EDB6149FB5D0Q40092095-B19151B5-EC0D-4E71-B3B6-225335273C81Q40198241-D40AC6D7-27E6-411D-8F0C-2E85DF83DF63Q40245350-83274094-979D-4BB7-BF40-96482E03F723Q41671765-B4566410-AAE6-48AF-A92A-91A88E7E7538Q41996352-BD00133B-9B6F-49F4-8192-EFA60542EA33
P2860
Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Involvement of neutrophils and ...... mab in xenograft tumor models.
@en
Involvement of neutrophils and ...... mab in xenograft tumor models.
@nl
type
label
Involvement of neutrophils and ...... mab in xenograft tumor models.
@en
Involvement of neutrophils and ...... mab in xenograft tumor models.
@nl
prefLabel
Involvement of neutrophils and ...... mab in xenograft tumor models.
@en
Involvement of neutrophils and ...... mab in xenograft tumor models.
@nl
P2093
P2860
P1433
P1476
Involvement of neutrophils and ...... mab in xenograft tumor models.
@en
P2093
Bruce Roberts
Carrie Garron
Jacqueline Shields
Johanne M Kaplan
Paula Boutin
Srinivas Shankara
William M Siders
William Weber
Yanping Hu
P2860
P304
P356
10.3109/10428191003777963
P577
2010-07-01T00:00:00Z